Form 4 for XYL Xylem Inc.
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001209191-22-015605 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-03 | 2022-03-02 | XYL | Yarkadas Hayati | SVP | S - Sale | $87.87 | -43 | 8,255 | -0.5% | -$3,778 |
| D | 2022-03-03 | 2022-03-01 | XYL | Yarkadas Hayati | SVP | A - Grant | $0.00 | +3,458 | 11.7K | +42% | $0 |
| D | 2022-03-03 | 2022-03-01 | XYL | Yarkadas Hayati | SVP | A - Grant | $0.00 | +15.1K | 15.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-02 | S | D | 43 | $87.87 | 8,255 | D | — | — | (F1) Reflects the sale of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (F2) This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price |
| 2 | Common | Common Stock | 2022-03-01 | A | A | 3,458 | $0.00 | 11,713 | D | — | — | (F3) Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2023, March 1, 2024 and March 1, 2025 |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-03-01 | A | A | 15,106 | $0.00 | 15,106 | D | $86.76 · — to 2032-03-01 | 15,106 Common | (F4) Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2023, March 1, 2024 and March 1, 2025. |